Report overview
Developing, optimising, and manufacturing Advanced Therapy Medicinal Products (ATMP?s), such as Cell and Gene Therapy (CGT) products is extremely complex. The choice of a reliable Contract Development Manufacturing Organisation (CDMO) is one of the most critical steps determining your product?s future.
This report aims to provide a comprehensive presentation of the global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services. This report contains market size and forecasts of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services in global, including the following market information:
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gene Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services include AGC Biologics, BlueReg, Bio Elpida, Celonic, CGT Catapult, Catalent, Cellipont Bioservices, Lonza and Minaris Regenerative Medicine, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Segment Percentages, by Type, 2022 (%)
Gene Therapy
Cell Therapy
Tissue Engineered
Others
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiology
Central Nervous System
Others
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AGC Biologics
BlueReg
Bio Elpida
Celonic
CGT Catapult
Catalent
Cellipont Bioservices
Lonza
Minaris Regenerative Medicine
Patheon
Rentschler Biopharma SE
Recipeharm
WuXi Advanced Therapies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, market overview.
Chapter 2: Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market size in revenue.
Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
